Stephen Wills

Stephen T.
Wills is an Independent Director at MediWound Ltd. since 2022.
He serves as COO, CFO, Secretary, Treasurer, and Executive VP at Palatin Technologies, Inc. since 2011.
He is a member of The American Institute of Certified Public Accountants, New Jersey Society of Certified Public Accountants, and Pennsylvania Institute of Certified Public Accountants.
Formerly, Mr. Wills was Executive Chairman and Chief Executive Officer at Derma Sciences, Inc. from 2015 to 2017 and Chairman and Chief Executive Officer at Derma Sciences Canada, Inc. during the same period.
He was Chairman at U.S.
Helicopter Corp.
from 2006 to 2010 and Chairman at Caliper Corp.
from 2016 to 2019.
He held the Chairman position at Hun School of Princeton, Inc. from 2018 to 2023.
He was a Non-Executive Director at Amryt Pharma PLC and Amryt Pharma Holdings Ltd. from 2019 to 2023.
He was an Independent Director at Gamida Cell Ltd. from 2019 to 2024 and at Enzon Pharmaceuticals, Inc. from 2025 to 2026.
He was Chief Financial Officer at Cactus Acquisition Corp.
1 Ltd. from 2021 to 2024 and briefly in 2024.
He was President and Chief Operating Officer at Golomb Wills & Co. CPA and Wills, Owens & Baker Pc from 1991 to 2000.
He held roles including Vice President-International Business at Biogen, Inc., and Head-Worldwide Marketing & Cardiovascular at Sanofi-Synthélabo Ltd. Education includes a graduate degree from Temple University (Pennsylvania) in 1994 and an undergraduate degree from West Chester University of Pennsylvania in 1979.